![]()
|
|
||||||||
J Biol Chem, Vol. 273, Issue 27, 17036-17049, July 3, 1998
From the ¶ Department of Anesthesia and the Liver
Center, University of California, San Francisco, California 94143, the A model of cytochrome P450 2B4, which was
constructed by homology modeling with the four known crystal structures
of the cytochromes P450 (Chang, T.-T., Stiffelman, O. B., Vakser,
I. A., Loew, G. H., Bridges, A., and Waskell, L. (1997)
Protein Eng. 10, 119-129), was used to select amino acids
predicted, by computer docking studies and numerous previous
biochemical and site-directed mutagenesis studies, to be involved in
binding the heme domain of cytochrome b5.
Twenty-four amino acid residues located on both the distal and the
proximal surface of the molecule were chosen for mutagenesis. These 24 mutant proteins were expressed in Escherichia coli,
purified, and characterized with respect to their ability to bind
cytochrome b5 and support substrate oxidation.
Seven mutants, R122A, R126A, R133A, F135A, M137A, K139A, and K433A, all
on the proximal surface of cytochrome P450 2B4 near the heme ligand,
were identified that exhibited decreased ability to bind cytochrome
b5. All of the mutants except K433A are located
in either the C or C* helices or their termini. In addition, these
seven mutants and two additional mutants on the proximal surface of
cytochrome P450, R422A and R443A, were shown to exhibit decreased
binding to cytochrome P450 reductase. These studies indicate that the
binding sites for cytochrome b5 and cytochrome
P450 reductase are, as predicted, located on the proximal surface of
cytochrome P450 2B4 and are partially overlapping but not
identical.
Identification of the Binding Site on Cytochrome P450 2B4 for
Cytochrome b5 and Cytochrome P450
Reductase
,
,
, and
Department of Anesthesia, Veterans Affairs Medical
Center, San Francisco, California 94121, the
Molecular
Research Institute, Palo Alto, California 94304, and the
** Department of Pharmacology, Medical University of South Carolina,
Charleston, South Carolina 29425
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
Y. Wada, M. Mitsuda, Y. Ishihara, M. Watanabe, M. Iwasaki, and S. Asahi Important Amino Acid Residues that Confer CYP2C19 Selective Activity to CYP2C9 J. Biochem., September 1, 2008; 144(3): 323 - 333. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Oezguen, S. Kumar, A. Hindupur, W. Braun, B. K. Muralidhara, and J. R. Halpert Identification and Analysis of Conserved Sequence Motifs in Cytochrome P450 Family 2: FUNCTIONAL AND STRUCTURAL ROLE OF A MOTIF 187RFDYKD192 IN CYP2B ENZYMES J. Biol. Chem., August 1, 2008; 283(31): 21808 - 21816. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, D. Hamdane, S.-C. Im, and L. Waskell Cytochrome b5 Inhibits Electron Transfer from NADPH-Cytochrome P450 Reductase to Ferric Cytochrome P450 2B4 J. Biol. Chem., February 29, 2008; 283(9): 5217 - 5225. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, S.-C. Im, and L. Waskell Cytochrome b5 Increases the Rate of Product Formation by Cytochrome P450 2B4 and Competes with Cytochrome P450 Reductase for a Binding Site on Cytochrome P450 2B4 J. Biol. Chem., October 12, 2007; 282(41): 29766 - 29776. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Mao, S. G. Rupasinghe, A. R. Zangerl, M. R. Berenbaum, and M. A. Schuler Allelic Variation in the Depressaria pastinacella CYP6AB3 Protein Enhances Metabolism of Plant Allelochemicals by Altering a Proximal Surface Residue and Potential Interactions with Cytochrome P450 Reductase J. Biol. Chem., April 6, 2007; 282(14): 10544 - 10552. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kumar, H. Liu, and J. R. Halpert Engineering of Cytochrome P450 3A4 for Enhanced Peroxide-Mediated Substrate Oxidation Using Directed Evolution and Site-Directed Mutagenesis Drug Metab. Dispos., December 1, 2006; 34(12): 1958 - 1965. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Robins, J. Carlsson, M. Sunnerhagen, A. Wedell, and B. Persson Molecular Model of Human CYP21 Based on Mammalian CYP2C5: Structural Features Correlate with Clinical Severity of Mutations Causing Congenital Adrenal Hyperplasia Mol. Endocrinol., November 1, 2006; 20(11): 2946 - 2964. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Gao, C. E. Doneanu, S. A. Shaffer, E. T. Adman, D. R. Goodlett, and S. D. Nelson Identification of the Interactions between Cytochrome P450 2E1 and Cytochrome b5 by Mass Spectrometry and Site-directed Mutagenesis J. Biol. Chem., July 21, 2006; 281(29): 20404 - 20417. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Janner, A. V Pandey, P. E Mullis, and C. E Fluck Clinical and biochemical description of a novel CYP21A2 gene mutation 962_963insA using a new 3D model for the P450c21 protein. Eur. J. Endocrinol., July 1, 2006; 155(1): 143 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Muralidhara, S. Negi, C. C. Chin, W. Braun, and J. R. Halpert Conformational Flexibility of Mammalian Cytochrome P450 2B4 in Binding Imidazole Inhibitors with Different Ring Chemistry and Side Chains: SOLUTION THERMODYNAMICS AND MOLECULAR MODELING J. Biol. Chem., March 24, 2006; 281(12): 8051 - 8061. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhao, M. A. White, B. K. Muralidhara, L. Sun, J. R. Halpert, and C. D. Stout Structure of Microsomal Cytochrome P450 2B4 Complexed with the Antifungal Drug Bifonazole: INSIGHT INTO P450 CONFORMATIONAL PLASTICITY AND MEMBRANE INTERACTION J. Biol. Chem., March 3, 2006; 281(9): 5973 - 5981. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. DeLozier, S.-C. Lee, S. J. Coulter, B. C. Goh, and J. A. Goldstein Functional Characterization of Novel Allelic Variants of CYP2C9 Recently Discovered in Southeast Asians J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1085 - 1090. [Abstract] [Full Text] [PDF] |
||||
![]() |
M K Akhtar, S L Kelly, and M A Kaderbhai Cytochrome b5 modulation of 17{alpha} hydroxylase and 17-20 lyase (CYP17) activities in steroidogenesis J. Endocrinol., November 1, 2005; 187(2): 267 - 274. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ozalp, E. Szczesna-Skorupa, and B. Kemper BIMOLECULAR FLUORESCENCE COMPLEMENTATION ANALYSIS OF CYTOCHROME P450 2C2, 2E1, AND NADPH-CYTOCHROME P450 REDUCTASE MOLECULAR INTERACTIONS IN LIVING CELLS Drug Metab. Dispos., September 1, 2005; 33(9): 1382 - 1390. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kumar, D. R. Davydov, and J. R. Halpert ROLE OF CYTOCHROME B5 IN MODULATING PEROXIDE-SUPPORTED CYP3A4 ACTIVITY: EVIDENCE FOR A CONFORMATIONAL TRANSITION AND CYTOCHROME P450 HETEROGENEITY Drug Metab. Dispos., August 1, 2005; 33(8): 1131 - 1136. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L. Miller Minireview: Regulation of Steroidogenesis by Electron Transfer Endocrinology, June 1, 2005; 146(6): 2544 - 2550. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wen, J. Baudry, M. R. Berenbaum, and M. A. Schuler Ile115Leu mutation in the SRS1 region of an insect cytochrome P450 (CYP6B1) compromises substrate turnover via changes in a predicted product release channel Protein Eng. Des. Sel., April 1, 2005; 18(4): 191 - 199. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Higashimoto, H. Sakamoto, S. Hayashi, M. Sugishima, K. Fukuyama, G. Palmer, and M. Noguchi Involvement of NADP(H) in the Interaction between Heme Oxygenase-1 and Cytochrome P450 Reductase J. Biol. Chem., January 7, 2005; 280(1): 729 - 737. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Von Weymarn, C. Sridar, and P. F. Hollenberg Identification of Amino Acid Residues Involved in the Inactivation of Cytochrome P450 2B1 by Two Acetylenic Compounds: The Role of Three Residues in Nonsubstrate Recognition Sites J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 71 - 79. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Clarke, S.-C. Im, A. Bidwai, and L. Waskell The Role of the Length and Sequence of the Linker Domain of Cytochrome b5 in Stimulating Cytochrome P450 2B4 Catalysis J. Biol. Chem., August 27, 2004; 279(35): 36809 - 36818. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Scott, M. A. White, Y. A. He, E. F. Johnson, C. D. Stout, and J. R. Halpert Structure of Mammalian Cytochrome P450 2B4 Complexed with 4-(4-Chlorophenyl)imidazole at 1.9-A Resolution: INSIGHT INTO THE RANGE OF P450 CONFORMATIONS AND THE COORDINATION OF REDOX PARTNER BINDING J. Biol. Chem., June 25, 2004; 279(26): 27294 - 27301. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yamaguchi, K. K. Khan, Y. A. He, Y. Q. He, and J. R. Halpert TOPOLOGICAL CHANGES IN THE CYP3A4 ACTIVE SITE PROBED WITH PHENYLDIAZENE: EFFECT OF INTERACTION WITH NADPH-CYTOCHROME P450 REDUCTASE AND CYTOCHROME B5 AND OF SITE-DIRECTED MUTAGENESIS Drug Metab. Dispos., January 1, 2004; 32(1): 155 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. F. Johnson THE 2002 BERNARD B. BRODIE AWARD LECTURE: Deciphering Substrate Recognition by Drug-Metabolizing Cytochromes P450 Drug Metab. Dispos., December 1, 2003; 31(12): 1532 - 1540. [Full Text] [PDF] |
||||
![]() |
E. E. Scott, Y. A. He, M. R. Wester, M. A. White, C. C. Chin, J. R. Halpert, E. F. Johnson, and C. D. Stout From The Cover: An open conformation of mammalian cytochrome P450 2B4 at 1.6-A resolution PNAS, November 11, 2003; 100(23): 13196 - 13201. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kimura and T. Iyanagi High-Level Expression of Porcine Liver Cytochrome P-450 Reductase Catalytic Domain in Escherichia coli by Modulating the Predicted Local Secondary Structure of mRNA J. Biochem., September 1, 2003; 134(3): 403 - 413. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Szczesna-Skorupa, B. Mallah, and B. Kemper Fluorescence Resonance Energy Transfer Analysis of Cytochromes P450 2C2 and 2E1 Molecular Interactions in Living Cells J. Biol. Chem., August 15, 2003; 278(33): 31269 - 31276. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang and P. R. O. de Montellano The Binding Sites on Human Heme Oxygenase-1 for Cytochrome P450 Reductase and Biliverdin Reductase J. Biol. Chem., May 23, 2003; 278(22): 20069 - 20076. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Facchiano, K. Russo, A. M. Facchiano, F. De Marchis, F. Facchiano, D. Ribatti, M. S. Aguzzi, and M. C. Capogrossi Identification of a Novel Domain of Fibroblast Growth Factor 2 Controlling Its Angiogenic Properties J. Biol. Chem., February 28, 2003; 278(10): 8751 - 8760. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tovchigrechko, C. A. Wells, and I. A. Vakser Docking of protein models Protein Sci., August 1, 2002; 11(8): 1888 - 1896. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Y. H. Zhang, X. Wang, J. T. Wang, N. A. Compagnone, S. H. Mellon, J. L. Olson, H. S. Tenenhouse, W. L. Miller, and A. A. Portale Dietary Phosphorus Transcriptionally Regulates 25-Hydroxyvitamin D-1{alpha}-Hydroxylase Gene Expression in the Proximal Renal Tubule Endocrinology, February 1, 2002; 143(2): 587 - 595. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. Cawley, S. Zhang, R. W. Kelley, and W. L. Backes Evidence Supporting the Interaction of CYP2B4 and CYP1A2 in Microsomal Preparations Drug Metab. Dispos., December 1, 2001; 29(12): 1529 - 1534. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tovchigrechko and I. A. Vakser How common is the funnel-like energy landscape in protein-protein interactions? Protein Sci., August 1, 2001; 10(8): 1572 - 1583. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Schulz-Utermoehl, R. J. Mountfield, R. P. Bywater, K. Madsen, P. N. Jørgensen, and K. T. Hansen Structure-Function Analysis of Human CYP3A4 Using a Specific Proinhibitory Antipeptide Antibody Drug Metab. Dispos., July 1, 2000; 28(7): 718 - 725. [Abstract] [Full Text] |
||||
![]() |
I. A. Vakser, O. G. Matar, and C. F. Lam A systematic study of low-resolution recognition in protein-protein complexes PNAS, July 20, 1999; 96(15): 8477 - 8482. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. F. Sevrioukova, H. Li, H. Zhang, J. A. Peterson, and T. L. Poulos Structure of a cytochrome P450-redox partner electron-transfer complex PNAS, March 2, 1999; 96(5): 1863 - 1868. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yamazaki, T. Shimada, M. V. Martin, and F. P. Guengerich Stimulation of Cytochrome P450 Reactions by Apo-cytochrome b5. EVIDENCE AGAINST TRANSFER OF HEME FROM CYTOCHROME P450 3A4 TO APO-CYTOCHROME b5 OR HEME OXYGENASE J. Biol. Chem., August 10, 2001; 276(33): 30885 - 30891. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |